Robert Habib (Credit: Imperial College London)

Mi­NA Ther­a­peu­tics bags near­ly $30M Se­ries A to push ac­ti­vat­ing mR­NA tech through the clin­ic

Sev­en years af­ter leav­ing in­vest­ment bank­ing to take the helm at Mi­NA Ther­a­peu­tics, CEO Robert Habib is on a mis­sion to de­vel­op a “new class …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.